Sonnendecker E W, Beale P G
Department of Obstetrics and Gynaecology, University of Witwatersrand, Johannesburg, South Africa.
Int Surg. 1989 Jan-Mar;74(1):10-2.
A nine year experience with rectosigmoid colectomy during primary cytoreductive surgery for epithelial ovarian cancer is reported. During the period 1979-1987, 20 patients underwent such resections with primary sutured end-to-end anastomosis without a protecting colostomy. Only one of these patients required a secondary colostomy. In a further five patients, anterior resection and reanastomosis was performed concomitant with additional bowel resections, again without diversion colostomy. Subsequent secondary colostomy for a recto-vaginal fistula was required in one. There were two post-operative deaths, both in the group who required bowel resections in addition to recto-sigmoid resection. Of the entire group of 25 patients, 12 (48%) are currently alive free of disease, with a median survival of 32 months. Excluding the two post-operative deaths (at 20 and 39 days), the median survival of the remaining 11 who subsequently died of recurrent disease, was 14 months. The Authors recommend that anterior resection with primary reanastomosis without a protecting colostomy, is performed during primary cytoreductive surgery for ovarian cancer in patients in whom such a procedure facilitates resection of all or nearly all their disease.
本文报道了对上皮性卵巢癌进行初次肿瘤细胞减灭术时行直肠乙状结肠切除术的九年经验。在1979年至1987年期间,20例患者接受了此类切除术,采用端端吻合的一期缝合,未行保护性结肠造口术。这些患者中只有1例需要二期结肠造口术。另有5例患者在进行额外肠段切除的同时进行了前切除术和再次吻合术,同样未行转流性结肠造口术。其中1例因直肠阴道瘘需要二期结肠造口术。有2例术后死亡,均在除直肠乙状结肠切除外还需要肠段切除的患者组中。在整个25例患者组中,12例(48%)目前无病存活,中位生存期为32个月。排除2例术后死亡患者(分别在术后20天和39天),其余11例随后死于复发性疾病的患者的中位生存期为14个月。作者建议,对于在初次肿瘤细胞减灭术中进行该手术有助于切除全部或几乎全部病灶的卵巢癌患者,行前切除术并一期再次吻合,不进行保护性结肠造口术。